Helus Pharma Statistics
NASDAQ: HELPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.11-0.67 (-9.88%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Helus Pharma by the numbers
Helus Pharma has a market capitalization of $487.7 million based on 79.81M shares outstanding. With trailing EPS of $-4.25, Helus Pharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 42.6% below its 50-day average and 21.7% below its 200-day average.
Average daily trading volume is 1.83M shares, or about $11.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
HELP valuation vs. peer median
| Metric | HELP | Peer median | Difference |
|---|---|---|---|
| Market cap | $487.68M | $466.59M | +5% |
| Avg. volume | 1.83M | 250.46K | +631% |
Peer median across 8 companies: WVE, EVO, MNPR, RZLT, ALMS, BLSM, GYRE, NGNE.
Valuation
- Market cap
- $487.68M
- EPS (TTM)
- $-4.25
- Shares outstanding
- 79.81M
Price and trading
- Previous close
- 6.78
- Open
- 6.63
- Day range
- 6.05 – 6.73
- 52-week range
- 3.76 – 15.15
- 52-week change
- +9.30%
- Beta
- —
- Volume
- 2.50M
- Average volume
- 1.83M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 487.68M
- Forward Pe
- -2.48
- Eps
- -4.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.15
- Week52 Low
- 3.76
- Avg Volume
- 1.83M
- Shares Outstanding
- 79.81M
- Ma50
- 10.65
- Ma200
- 7.80
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -59.67%
- Pct From52w Low
- 62.50%